Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-14 · accession 0000950170-24-061294 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-05-16 | 2024-05-14+ | AMLX | Quimi Daphne | Dir | P - Purchase | $1.89 | +5,000 | 5,000 | New | +$9,450 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-14 | P | A | 2,750 | $1.89 | 2,750 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-15 | P | A | 2,250 | $1.89 | 5,000 | D | — | — |